Abbott Infant Formula Shortage: 3 ECRI Recommendations

Posted by Edward Nuber, Director of Marketing, ECRI on May 18, 2022

Infant formula shortage is all over the news. The White House is taking emergency actions, while mothers, fathers and families are feeling the brunt of the shortage.  

On February 17, 2022, Abbott initiated a proactive, voluntary recall of powder formulas, including Similac, Alimentum and EleCare manufactured in Sturgis, Michigan, because of possible Cronobacter sakazakii or Salmonella Newport contamination.

Read More

Topics: Risk Management, Patient Safety, ECRI, Public Health, Baby Formula Recall, Abbott Infant Formula Shortage, Formula Manufacturers

Knowledge is Power

Our evidence supports the advancement of care around the world. Read our articles, get industry updates and trends, and learn a little more about us on the ECRI blog.

Subscribe for Email Updates

Recent Posts

Posts by Topic

See all